Company: CDLX
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0001666071-25-000126
Chunk: 100

Company: Cardlytics, Inc.
Filing Date: 2025-08-06
Form: 10-Q
Item: Item 1
Chunk 100
---
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

2

Table of Contents

CARDLYTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Amounts in thousands, except par value amounts)

June 30, 2025December 31, 2024AssetsCurrent assets:Cash and cash equivalents$46,745 $65,594 Accounts receivable and contract assets, net93,189 103,252 Other receivables3,431 3,801 Prepaid expenses and other assets7,035 5,336 Total current assets150,400 177,983 Long-term assets:Property and equipment, net2,389 2,596 Right-of-use assets under operating leases, net4,633 6,341 Intangible assets, net8,462 11,371 Goodwill159,429 159,429 Capitalized software development costs, net34,415 33,341 Other long-term assets, net1,406 1,650 Total assets$361,134 $392,711 Liabilities and stockholders' equityCurrent liabilities:Accounts payable$1,945 $3,689 Accrued liabilities:Accrued compensation7,244 5,494 Accrued expenses6,457 7,175 Partner Share liability27,196 32,479 Consumer Incentive liability35,996 45,513 Short-term debt46,009 45,863 Deferred revenue3,103 2,154 Current operating lease liabilities1,199 2,025 Current contingent consideration— 4,563 Total current liabilities129,149 148,955 Long-term liabilities:Convertible senior notes, net168,289 167,729 Long-term operating lease liabilities4,915 6,034 Long-term deferred revenue75 — Total liabilities$302,428 $322,718 Stockholders’ equity:Common stock, $0.0001 par value—100,000 shares authorized, 52,994 and 51,257 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively$10 $10 Additional paid-in capital1,385,465 1,366,958 Accumulated other comprehensive (loss) income(3,628)3,601 Acc